PubMed Health⌕ Search

Biomedical subjects

C R Conti

Publications and source records attributed to C R Conti.

At least 55 records · Page 3Linked to original sources
PubMed1999

Continuing medical education and industry support.

1. Industry and faculty of continuing medical education programs must agree that any supported program is for scientific and educational purposes only and not to promote a company's products directly or indirectly. 2. The control of content and selection of presenters and moderators must be independent of the company and determined by the program director. 3. Faculty of continuing medical education programs must disclose any financial relationship they have with the sponsoring company. 4. Program content cannot be scripted or influenced in any way by industry. 5. Objectivity and balance must be perceived by the audience. This includes the presentation of favorable and unfavorable information and alternative treatments. 6. Incomplete data must be identified by the faculty. Oftentimes, much of what is presented at continuing medical education programs has not yet been published in peer-reviewed journals. This must be so indicated by the presenter, and it should be specified whether incomplete data is on-going research, analysis, preliminary data, or unsupported opinion. 7. Support from industry must be in the form of an educational grant with no strings attached.

Drug Industry↗
PubMed1998

Clinical and detailed angiographic findings in patients with ambulatory electrocardiographic ischemia without critical coronary narrowing: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study.

BACKGROUND: Patients with ambulatory electrocardiographic (AECG) ST-segment depression and critical coronary narrowing are known to be at increased risk for adverse outcome, but little is known about patients with AECG ST-segment depression without critical coronary narrowing. HYPOTHESIS: The objectives of this study were to characterize the coronary angiographic pathology in patients with AECG ST-segment depression but without critical (< 50% diameter stenosis) coronary narrowing and to compare demographic and clinical findings in these patients with those enrolled in the Asymptomatic Cardiac Ischemia Pilot Study with AECG ST-segment depression and critical (> or = 50% diameter stenosis) coronary narrowing. METHODS: Coronary angiograms from patients with AECG ST-segment depression were reviewed in a central laboratory and quantitative measurement of percent stenosis was performed. Clinical and angiographic comparisons were made between patients with and without critical coronary narrowing. RESULTS: Patients without critical coronary narrowing (n = 64) were younger (p = 0.02), less likely to be male (p < 0.001) or to have risk factors for coronary atherosclerosis or a history of myocardial infarction (p < 0.001), and had fewer ischemic episodes per 24 h on the screening AECG (p = 0.02) than patients with critical coronary narrowing (n = 441). Of patients without critical narrowing, one half had angiographic evidence for coronary artery disease (> or = 20% stenosis) and 60% had an ejection fraction > 70%. CONCLUSIONS: Patients with AECG ST-segment depression without critical coronary narrowing are heterogeneous, with half having measurable coronary artery disease. Demographically and clinically, they appear to be different than patients with AECG ST-segment depression with critical coronary narrowing.

Coronary Angiography↗